
|Articles|March 1, 2012
- Applied Clinical Trials-03-01-2012
- Volume 21
- Issue 3
Act Cover
Cover
Advertisement
Cover
Articles in this issue
over 14 years ago
Re-Imagining CTMSover 14 years ago
Applied Clinical Trials Digital Edition - March 2012over 14 years ago
PDUFA Renewal Seeks Development Incentivesover 14 years ago
Biosimilar Guidances Issuedover 14 years ago
Increased eCRF Reuse Not Impacting Cycle Times?over 14 years ago
Site-Driven Metricsover 14 years ago
Rethinking the Adage Time is Moneyover 14 years ago
How Much Information for Informed Consent?over 14 years ago
New Patient Group Targets DIA EuroMeetingAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
3
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5




